Christopher James Stevens is Chief Operating Officer of ROCKET PHARMACEUTICALS, INC.. Currently has a direct ownership of 407,166 shares of RCKT, which is worth approximately $1.23 Million. The most recent transaction as insider was on Aug 04, 2025, when has been sold 407,166 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 407K
n/a 3M change
n/a 12M change
Total Value Held $1.23 Million

Christopher James Stevens Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 04 2025
BUY
Grant, award, or other acquisition
-
407,166 Added 50.0%
407,166 Common Stock
CJS

Christopher James Stevens

Chief Operating Officer
Cranbury, NJ

Track Institutional and Insider Activities on RCKT

Follow ROCKET PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RCKT shares.

Notify only if

Insider Trading

Get notified when an Rocket Pharmaceuticals, Inc. insider buys or sells RCKT shares.

Notify only if

News

Receive news related to ROCKET PHARMACEUTICALS, INC.

Track Activities on RCKT